Maternal Immunization Studies Should Vary By Antigen, Panel Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Adequacy of serological endpoints, duration and nature of safety follow-up, and need for surveillance of immune interference with childhood vaccines will all depend upon the vaccine antigen used in maternal immunization, FDA advisory committee members said.